Bipolar disorder is a chronic, lifelong condition that causes recurrent and dramatic shifts in a person’s mood, energy and ability to think clearly. It is defined by recurrent episodes of depression and mania or hypomania. An estimated 37 million people worldwide live with the disorder, which can disrupt daily functioning and significantly impair relationships, work and overall quality of life. Because these symptoms can be similar to those of other mental health conditions, bipolar disorder is often misdiagnosed or undertreated.
An estimated 37 million people worldwide live with bipolar disorder.
J&J’s approach to bipolar disorder
Our portfolio includes the first and only approved therapy for the treatment of depressive episodes associated with bipolar I or II disorder in adults, as monotherapy and as adjunctive therapy with lithium or valproate in the U.S. We are committed to deepening our understanding of bipolar disorder and delivering breakthrough treatments and solutions for the greatest unmet patient needs.
